US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ACIU

AC Immune (ACIU)

AC Immune SA

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ACIU

1 2 3 4 5 6 7 8 9 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/12/19	07 : 16	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ACIU	AC Immune SA
2024/12/14	07 : 15	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:ACIU	AC Immune SA
2024/12/10	22 : 23	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ACIU	AC Immune SA
2024/12/10	21 : 00	GlobeNewswire Inc.	AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome	NASDAQ:ACIU	AC Immune SA
2024/11/14	21 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ACIU	AC Immune SA
2024/11/14	21 : 00	GlobeNewswire Inc.	AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease	NASDAQ:ACIU	AC Immune SA
2024/11/13	21 : 00	GlobeNewswire Inc.	AC Immune to Present at the Jefferies 2024 London Healthcare Conference	NASDAQ:ACIU	AC Immune SA
2024/11/05	21 : 15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ACIU	AC Immune SA
2024/11/05	21 : 00	GlobeNewswire Inc.	AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update	NASDAQ:ACIU	AC Immune SA
2024/09/28	05 : 26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ACIU	AC Immune SA
2024/09/20	05 : 30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ACIU	AC Immune SA
2024/09/19	05 : 40	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ACIU	AC Immune SA
2024/09/17	20 : 02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ACIU	AC Immune SA
2024/08/28	22 : 04	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ACIU	AC Immune SA
2024/08/07	05 : 50	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ACIU	AC Immune SA
2024/08/07	05 : 07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ACIU	AC Immune SA
2024/08/06	20 : 15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ACIU	AC Immune SA
2024/08/01	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ACIU	AC Immune SA
2024/07/31	21 : 35	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ACIU	AC Immune SA
2024/07/27	05 : 53	Edgar (US Regulatory)	Form F-3/A - Registration statement by foreign private issuers: [Amend]	NASDAQ:ACIU	AC Immune SA
2024/07/25	21 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ACIU	AC Immune SA
2024/05/21	21 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ACIU	AC Immune SA
2024/05/17	03 : 23	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ACIU	AC Immune SA
2024/05/13	19 : 16	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ACIU	AC Immune SA
2024/05/13	19 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ACIU	AC Immune SA
2024/02/10	06 : 30	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ACIU	AC Immune SA
2024/01/22	21 : 53	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ACIU	AC Immune SA
2024/01/04	06 : 19	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ACIU	AC Immune SA
2024/01/03	22 : 10	GlobeNewswire Inc.	AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases	NASDAQ:ACIU	AC Immune SA
2023/12/29	06 : 22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ACIU	AC Immune SA

Showing the most relevant articles for your search:NASDAQ:ACIU

1 2 3 4 5 6 7 8 9 次へ >>

Energy Select Sector SPDR

US Dollar vs Euro

Gold vs US Dollar

Bank of America

Health Care Select Sector

US Dollar vs Sterling

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約